Sussex Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
      • 5.1 Amoebic infection
      • 5.2 Bacterial infection
      • 5.3 Fungal infection
      • 5.4 Helminth infection
      • 5.5 Protozoal infection
      • 5.6 Viral infection
        • 5.6.1 Coronavirus
        • 5.6.2 Hepatitis
        • 5.6.3 Hepatitis infections
        • 5.6.3a Chronic hepatitis B
        • 5.6.3b Chronic hepatitis C
        • 5.6.3c Chronic hepatitis D
        • 5.6.4 Herpesvirus infections
        • 5.6.4a Cytomegalovirus infections
        • 5.6.5 HIV infection
        • 5.6.6 Influenza
        • 5.6.7 Respiratory syncytial virus
      • 5.7 Other Infection items
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

5.6.3a Chronic hepatitis B

Adefovir

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Adefovir 10mg tablets

Pack
30 tablet

Entecavir

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Entecavir 500microgram tablets

Pack
30 tablet

Entecavir 1mg tablets

Pack
30 tablet

Entecavir 50micrograms/ml oral solution sugar free

Pack
210 ml

Peginterferon alfa-2a

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Pegasys 90micrograms/0.5ml solution for injection pre-filled syringes

Pack
1 pre-filled disposable injection

Pegasys 135micrograms/0.5ml solution for injection pre-filled syringes

Pack
1 pre-filled disposable injection

Pegasys 180micrograms/0.5ml solution for injection pre-filled syringes

Pack
4 pre-filled disposable injection

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026